Apellis Pharmaceuticals
APLS
#3071
Rank
โ‚น502.57 B
Marketcap
โ‚น3,926
Share price
0.00%
Change (1 day)
162.12%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Apellis Pharmaceuticals CIK: 0001492422

Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2026-02-24

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2025-02-28

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2024-02-27

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2023-02-21

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2022-02-28

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2021-02-25

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2020-02-27

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2019-02-26

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report

10-K Annual Report 2018-03-19

Language: English

View Annual Report (10-K)